Ali Dastranj Tabrizi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ali Dastranj Tabrizi has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Morteza Ghojazadeh
Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran
8 shared publications - Manizheh Sayyah-Melli
Women’s Reproductive Health Research Center, Tabriz University of medical sciences, Tabriz, Iran
7 shared publications - Elaheh Ouladsahebmadarek
Women’s Reproductive Health Research Center, Tabriz University of medical sciences, Tabriz, Iran
5 shared publications - Amir Vahedi
Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
4 shared publications - Jalal Gharesouran
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
4 shared publications Leila Kafshdooz
4 shared publications
Latest Publications
- 7 April 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (2) , 1-9
The Clinicopathological and Prognostic Values of Chemotherapy Response Score in Tubo-Ovarian High-Grade Serous Carcinoma
- 7 April 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (2) , 1-9
The Clinicopathological and Prognostic Values of Chemotherapy Response Score in Tubo-Ovarian High-Grade Serous Carcinoma
- Open Access
- 10 January 2017
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 6 (1) , 2-5
Atrophic Pap Smears, Differential Diagnosis and Pitfalls: A Review
Taking Pap smear in postmenopausal women occasionally shows a hypocellular background and may display the absence of endocervical or transformation zone components (6,7) (Figure 1A). Microscopic examination of atrophic smears which is typically seen in postmenopausal women usually shows numerous parabasal and intermediate cells that may be arranged in small clusters or as individual cells (Figure 1B and C). A small number of superficial cells may be seen. Presence of a large number of superficial cells along with intermediate cells may indicate the need for hormone replacement therapy or uterine prolapse treatment. In these circumstances, parakeratotic cells may also be seen and should not be considered as evidence of low grade squamous intraepithelial lesion (LSIL). The parabasal cells usually show a relatively small amount of cytoplasm and high nuclear/cytoplasmic ratio. The condensed nuclear chromatin leads to nuclear hyperchromasia, however, no chromatin clumping and no nucleoli is seen. Absence of chromatin clumping, sharp and regular nuclear membrane and absence of mitotic figure are hallmarks of atrophic smears which allow easy distinction of these cases from high grade intraepithelial or malignant lesions
- 10 January 2017
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 6 (1) , 2-5
Open AccessAtrophic Pap Smears, Differential Diagnosis and Pitfalls: A Review
Taking Pap smear in postmenopausal women occasionally shows a hypocellular background and may display the absence of endocervical or transformation zone components (6,7) (Figure 1A). Microscopic examination of atrophic smears which is typically seen in postmenopausal women usually shows numerous parabasal and intermediate cells that may be arranged in small clusters or as individual cells (Figure 1B and C). A small number of superficial cells may be seen. Presence of a large number of superficial cells along with intermediate cells may indicate the need for hormone replacement therapy or uterine prolapse treatment. In these circumstances, parakeratotic cells may also be seen and should not be considered as evidence of low grade squamous intraepithelial lesion (LSIL). The parabasal cells usually show a relatively small amount of cytoplasm and high nuclear/cytoplasmic ratio. The condensed nuclear chromatin leads to nuclear hyperchromasia, however, no chromatin clumping and no nucleoli is seen. Absence of chromatin clumping, sharp and regular nuclear membrane and absence of mitotic figure are hallmarks of atrophic smears which allow easy distinction of these cases from high grade intraepithelial or malignant lesions
- 15 September 2016
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (4) , 152-156
Histologic Features and Differential Diagnosis of Endometrial Polyps; An Update and Review
- 15 September 2016
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (4) , 152-156
Histologic Features and Differential Diagnosis of Endometrial Polyps; An Update and Review
- Open Access
- 8 June 2016
- Published by SciDoc Publishers LLC in International Journal of Anatomy & Applied Physiology
- p. 39-42
Accuracy of Fine Needle Aspiration of Pelvic Masses, A Cyto-histological Correlation
- 8 June 2016
- Published by SciDoc Publishers LLC in International Journal of Anatomy & Applied Physiology
- p. 39-42
Open AccessAccuracy of Fine Needle Aspiration of Pelvic Masses, A Cyto-histological Correlation
- Open Access
- 22 March 2016
- Published by Springer Nature in Diagnostic Pathology
- Vol. 11 (1) , 30
Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study
Ovarian epithelial cancers are among the most lethal women's cancers. There is no doubt about the preventive role of oral contraceptive pills (OCPs) in development of ovarian cancers. But, there are limited numbers of studies to address the effect of these agents on the number of cortical inclusion cysts (CICs), their epithelial type and suppression of the metaplastic phenomenon by these pills. The aim of this study was to clarify the role of these agents in the prevention of these cyst formation and tubal metaplasia and also examine the mesenchymal-epithelial transition theory in this context by immunohistochemical methods. The representative section(s) of ovarian cortex from a total number of 201 consecutive total abdominal hysterectomy with bilateral or unilateral salpingo-oophorectomy specimens were examined for mean number of CICs and their epithelial type between two groups of the patients. Group A included the patients who were on oral contraceptive pills for more than 5 years. All of the subjects with other contraceptive methods or a history of less than 5 years contraceptive pills usage were stratified in group B. Sections from 20 cases in which more than five inclusion cysts were found, were selected for IHC staining with calretinine and PAX8 as markers for mesothelium and mullerian epithelium respectively. The mean age of the patients was 51.67 years with no significant differences between two groups. The mean number of cysts were 1.27 and 3.23 in group A and B respectively (P =0.0001). Similarly the mean number of CICs, lined by tubal epithelium, was significantly different between two groups (0.65 vs 2.65, P =0.0001). In IHC staining 123 out of 150 CICs (82 %) were PAX+ while only 7 CICs (4.8 %) showed positive reaction for calretinin irrespective of type of epithelium. Our findings showed that the use of OCP for more than five years in women, significantly prevents development of cortical inclusion cysts in the ovaries which lined by tubal (PAX8 positive) type epithelium. These findings may explain the alternative mechanism of oral contraceptive pills or long time use of progesterone in suppression of tubal type overgrowth and subsequently prevention of ovarian epithelial cancers.
- 22 March 2016
- Published by Springer Nature in Diagnostic Pathology
- Vol. 11 (1) , 30
Open AccessImpact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study
Ovarian epithelial cancers are among the most lethal women's cancers. There is no doubt about the preventive role of oral contraceptive pills (OCPs) in development of ovarian cancers. But, there are limited numbers of studies to address the effect of these agents on the number of cortical inclusion cysts (CICs), their epithelial type and suppression of the metaplastic phenomenon by these pills. The aim of this study was to clarify the role of these agents in the prevention of these cyst formation and tubal metaplasia and also examine the mesenchymal-epithelial transition theory in this context by immunohistochemical methods. The representative section(s) of ovarian cortex from a total number of 201 consecutive total abdominal hysterectomy with bilateral or unilateral salpingo-oophorectomy specimens were examined for mean number of CICs and their epithelial type between two groups of the patients. Group A included the patients who were on oral contraceptive pills for more than 5 years. All of the subjects with other contraceptive methods or a history of less than 5 years contraceptive pills usage were stratified in group B. Sections from 20 cases in which more than five inclusion cysts were found, were selected for IHC staining with calretinine and PAX8 as markers for mesothelium and mullerian epithelium respectively. The mean age of the patients was 51.67 years with no significant differences between two groups. The mean number of cysts were 1.27 and 3.23 in group A and B respectively (P =0.0001). Similarly the mean number of CICs, lined by tubal epithelium, was significantly different between two groups (0.65 vs 2.65, P =0.0001). In IHC staining 123 out of 150 CICs (82 %) were PAX+ while only 7 CICs (4.8 %) showed positive reaction for calretinin irrespective of type of epithelium. Our findings showed that the use of OCP for more than five years in women, significantly prevents development of cortical inclusion cysts in the ovaries which lined by tubal (PAX8 positive) type epithelium. These findings may explain the alternative mechanism of oral contraceptive pills or long time use of progesterone in suppression of tubal type overgrowth and subsequently prevention of ovarian epithelial cancers.
- Open Access
- 1 January 2016
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (1) , 29-33
Diagnostic Value of Novel Biomarker Human Epididymis Protein 4 (HE4) in Detecting Endometrial Cancer
- 1 January 2016
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (1) , 29-33
Open AccessDiagnostic Value of Novel Biomarker Human Epididymis Protein 4 (HE4) in Detecting Endometrial Cancer
- Open Access
- 31 December 2015
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 5 (Suppl 1) , 683-687
Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma
Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma
- 31 December 2015
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 5 (Suppl 1) , 683-687
Open AccessImmunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma
Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma
- Open Access
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7449-7452
C-kit Mutations in Endometrial Cancer: Correlation with Tumor Histologic Type
C-kit Mutations in Endometrial Cancer: Correlation with Tumor Histologic Type Endometrial carcinoma;tumor type and grade;c-kit mutation; Objective: Endometrial cancer is the fourth most common cancer among women in developed countries. Affected patients may benefit from systemic chemotherapy, alone or in combination with targeted therapies if the disease is clinically diagnosed prior to expansion and metastasis to other organs. The aim of this study was to evaluate the prognostic role of c-kit mutations and comparision with tumor type and grade in human uterine endometrial carcinomas. Materials and Methods: Seventy five patients with endometrial carcinoma and seventy five normal controls were studied for possible mutations in exon 17 of the c-kit gene using single strand conformational polymorphisms and sequencing. Results: c-kit mutation in exon 17 appeared to be significantly different between endometrial carcinoma and normal endometrium. The pattern and frequency of the mutations was also shown to be different between tumors from different stages.
- 3 December 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (17) , 7449-7452
Open AccessC-kit Mutations in Endometrial Cancer: Correlation with Tumor Histologic Type
C-kit Mutations in Endometrial Cancer: Correlation with Tumor Histologic Type Endometrial carcinoma;tumor type and grade;c-kit mutation; Objective: Endometrial cancer is the fourth most common cancer among women in developed countries. Affected patients may benefit from systemic chemotherapy, alone or in combination with targeted therapies if the disease is clinically diagnosed prior to expansion and metastasis to other organs. The aim of this study was to evaluate the prognostic role of c-kit mutations and comparision with tumor type and grade in human uterine endometrial carcinomas. Materials and Methods: Seventy five patients with endometrial carcinoma and seventy five normal controls were studied for possible mutations in exon 17 of the c-kit gene using single strand conformational polymorphisms and sequencing. Results: c-kit mutation in exon 17 appeared to be significantly different between endometrial carcinoma and normal endometrium. The pattern and frequency of the mutations was also shown to be different between tumors from different stages.
- 21 September 2015
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (2) , 73-76
The Impact of Parity on the Number of Ovarian Cortical Inclusion Cysts
- 21 September 2015
- Published by International Journal of Women's Health and Reproduction Sciences in International Journal of Women's Health and Reproduction Sciences
- Vol. 4 (2) , 73-76
The Impact of Parity on the Number of Ovarian Cortical Inclusion Cysts
- Open Access
- 26 June 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (11) , 4521-4524
Role of exon 7 PTEN Gene in Endometrial Carcinoma
Role of exon 7 PTEN Gene in Endometrial Carcinoma Endometrial carcinoma;PTEN;exon 7;mutations; Background: Endometrial carcinoma is the most common malignant tumor of the female genital tract and the fourth most common cancer in Iranian women after breast, colorectal and lung cancers. Various genetic alterations appear to be early events in the pathogenesis of endometrial carcinoma and it seems that PTEN is the most commonly mutated gene in the endometrioid subtype. The aim of the present study was to investigate the correlation between mutations in exon 7 of PTEN gene and endometrial carcinoma. Materials and Methods: Seventy-five patients with endometrial carcinoma and 75 females whose underwent hysterectomy for non tumoral indication were selected for evaluation of PTEN mutations in exon 7 by PCR-SSCP and sequencing. Correlations between the frequency and type of mutation and the pathologic findings of the cancer (tumor subtype, stage and grade) were assessed. Results: All of the samples were obtained from Iranian patients. 60 % (45 cases) of the tumors were endometriod and 40% (30 cases) were of serous type. The grade distributions of the 75 cases according to the FIGO staging system were as follows: low grade, 20 cases; high grade 55 cases, low stage, 41 cases; high stage 34 cases. For exon 7 of the PTEN gene, the analysis showed that there were no mutations in our cases. Conclusions: Our findings in the present study suggest that exon 7 of PTEN does not play any significant role in the development of endometrial carcinoma in Iranian cases.
- 26 June 2015
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (11) , 4521-4524
Open AccessRole of exon 7 PTEN Gene in Endometrial Carcinoma
Role of exon 7 PTEN Gene in Endometrial Carcinoma Endometrial carcinoma;PTEN;exon 7;mutations; Background: Endometrial carcinoma is the most common malignant tumor of the female genital tract and the fourth most common cancer in Iranian women after breast, colorectal and lung cancers. Various genetic alterations appear to be early events in the pathogenesis of endometrial carcinoma and it seems that PTEN is the most commonly mutated gene in the endometrioid subtype. The aim of the present study was to investigate the correlation between mutations in exon 7 of PTEN gene and endometrial carcinoma. Materials and Methods: Seventy-five patients with endometrial carcinoma and 75 females whose underwent hysterectomy for non tumoral indication were selected for evaluation of PTEN mutations in exon 7 by PCR-SSCP and sequencing. Correlations between the frequency and type of mutation and the pathologic findings of the cancer (tumor subtype, stage and grade) were assessed. Results: All of the samples were obtained from Iranian patients. 60 % (45 cases) of the tumors were endometriod and 40% (30 cases) were of serous type. The grade distributions of the 75 cases according to the FIGO staging system were as follows: low grade, 20 cases; high grade 55 cases, low stage, 41 cases; high stage 34 cases. For exon 7 of the PTEN gene, the analysis showed that there were no mutations in our cases. Conclusions: Our findings in the present study suggest that exon 7 of PTEN does not play any significant role in the development of endometrial carcinoma in Iranian cases.